Consumer Defensive
Live Price
Offline$12.43
+0.81% today
1Y Change
-13.53%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Reckitt Benckiser Group plc (RBGLY) is a Consumer Defensive stock with a market cap of $30.20B and listed on OTC. The stock last traded around $12.43 and down 13.5% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -1.9%, EPS growth of +134.8%, a dividend yield of 9.8%. What stands out right now is revenue -1.9%, EPS +134.8%, free cash flow -22.3% with operating margin 32.4% and ROIC 15.4%. The dividend matters to the case here, with a current yield around 9.8%. Valuation is more restrained than many high-expectation growth names at P/E 11.3 and price/sales 2.8. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines RBGLY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RBGLY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RBGLY Max Drawdown
-31.78%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RBGLY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$13.2B
-8.4% YoY
FY Net Income
-$32.0M
-101.4% YoY
Free Cash Flow
$1.3B
-32.2% YoY
Revenue Growth
-1.9%
EPS Growth
+134.8%
Gross Margin
60.7%
Net Margin
25.2%
Income statement
GBP
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 13.9B | 14.2B | 14.6B | 14.5B | 13.2B |
| Gross Profit | 8.4B | 8.6B | 8.8B | 8.4B | 7.7B |
| Operating Income | 4.1B | 2.4B | 2.5B | 3.2B | -804M |
| EBITDA | 4.6B | 3.0B | 3.2B | 3.6B | 3.0B |
| Net Income | 3.1B | 1.4B | 1.6B | 2.3B | -32M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
GBP
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.9B | 760M | 1.4B | 1.2B | 1.3B |
| Total Assets | 25.0B | 25.3B | 27.1B | 28.7B | 26.9B |
| Total Liabilities | 17.3B | 18.6B | 18.7B | 19.3B | 19.5B |
| Shareholder Equity | 7.7B | 6.7B | 8.4B | 9.4B | 7.4B |
| Total Debt | 8.4B | 8.7B | 8.5B | 8.9B | 9.6B |
| Net Debt | 6.5B | 7.9B | 7.2B | 7.7B | 8.3B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1.7B
-29.2% YoY
Capital Expenditures
373M
+15.8% YoY
Free Cash Flow
1.3B
-32.2% YoY
Key ratios
Gross Margin
60.7%
Operating Margin
32.4%
Net Margin
25.2%
ROE
38.5%
Debt / Equity
1.09x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.